Management of an ABO-incompatible lung transplant

TitleManagement of an ABO-incompatible lung transplant
Publication TypeJournal Article
Year of Publication2004
AuthorsBanner NR, Rose ML, Cummins D, de Silva M, Pottle A, Lyster H, Doyle P, Carby M, Khaghani A
JournalAm J Transplant
Pagination1192 - 6
Date PublishedJul
ISSN1600-6135 (Print) 1600-6135 (Linking)
Accession Number15196081
Keywords*ABO Blood-Group System, *Blood Group Incompatibility, *Graft Rejection, Adult, Antigens, CD20 / biosynthesis, Cystic Fibrosis / therapy, Female, Heart Transplantation / *methods, Humans, Immunoglobulin G / immunology, Immunosorbent Techniques, Immunosuppressive Agents, Lung Transplantation / methods, Time Factors, Treatment Outcome

A 24-year-old woman with cystic fibrosis underwent bilateral sequential lung transplantation and unintentionally received an ABO incompatible graft (blood type A(1) graft into a type O recipient). The recipient had a high titer of IgG anti-A antibody (256 by the indirect antiglobulin test). Emergency treatment included antibody removal by plasmapheresis and additional immunosuppression with mycophenolate, rabbit antithymocyte globulin and polyspecific intravenous immunoglobulin. Subsequently, immunoadsorption and the anti-CD20 antibody rituximab were used to remove anti-A antibody and inhibit its resynthesis. Early graft function was good; one episode of rejection at Day 46 responded promptly to treatment with methylprednisolone. Subsequently, graft function continued to improve and anti-A antibody titers remained low. No infectious or other complications were encountered. The treatment regimen that we adopted may prove useful in other cases of unplanned ABO-incompatible organ transplants. The successful outcome suggests that planned ABO-incompatible lung transplants may be possible.

DOI10.1111/j.1600-6143.2004.00438.x AJT438 [pii]
Notify Library Reference ID127

Related Incidents